rethinkPeptides Search
Menu
Research citation

Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add-on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care (LIRA-PRIME).

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add-on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care (LIRA-PRIME).

Diabetes, obesity & metabolism, 24(2), 204-211

Citation

Unger, Jeff; Allison, Dale C; Kaltoft, Margit; Lakkole, Kavitha; Panda, Jayant K; Ramesh, Chethana; Sargin, Mehmet; Smolyarchuk, Elena; Twine, Melissa; Wolthers, Benjamin; Yarimbas, Gizem; Zoghbi, Marouan. (2022). Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add-on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care (LIRA-PRIME).. Diabetes, obesity & metabolism, 24(2), 204-211. https://doi.org/10.1111/dom.14566